Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation

Blood

Volumn 96, Issue 9, 2000, Pages 3056-3063

  Penn, Marc S ^a   Cui, Mei Zhen ^a   Winokur, Allison L ^a   Bethea, John ^a   Hamilton, Thomas A ^a   DiCorleto, Paul E ^a   Chisolm, Guy M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROPEROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ANTIOXIDANT; BLOOD CLOTTING FACTOR 7A; LIPID; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZING AGENT; OXYSTEROL; TERT BUTYL HYDROPEROXIDE; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA MEDIA; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CELL PROLIFERATION; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; THROMBOGENICITY;

EID: 0034332191     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.9.3056     Document Type: Article

References (51)

1. Factor IX is activated in vivo by the tissue factor mechanism
2. The activation of factor X and prothrombin by recombinant factor Vlla in vivo is mediated by tissue factor
3. The structural basis of function of the TF. Vlla complex in the cellular initiation of coagulation
4. Some thoughts about localization and expression of tissue factor
5. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
6. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury
7. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes
8. Monocyte tissue factor-like activity in post myocardial infarction patients
9. Tissue factor expression on macrophages in coronary plaques in patients with unstable angina
10. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes
11. LDL increases inactive tissue factor on vascular smooth muscle cell surfaces: Hydrogen peroxide activates latent cell surface tissue factor
12. Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1
13. Dietary lipid lowering reduces tissue factor expression in rabbit
14. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
15. Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells
16. 2+ mobilization and protein kinase C activation
17. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid
18. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle
19. Oxygen-mediated heterogeneity of apo-low-density lipoprotein
20. Protein measurement with the Folin phenol reagent
21. The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent
22. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals
23. Expression of type I and type II boville scavenger receptors in Chinese hamster ovary cells: Lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein
24. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
25. 7 Beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein
26. Roles of multiple oxidized LDL lipids in cellular injury: Dominance of 7 beta-hydroperoxycholesterol
27. Isoleukotrienes are biologically active free radical products of lipid peroxidation
28. A novel microtiter plate assay for the quantitation of procoagulant activity on adherent monocytes, macrophages and endothelial cells
29. Isolation of biologically active ribonucleic acid from sources enriched
30. A simplification of the protein assay method of Lowry et al which is more generally applicable
31. tert-Butyl hydroperoxide kills cultured hepatocytes by peroxidizing membrane lipids
32. Antioxidant effects of Ebselen (PZ 51): Peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity
33. Oxygen toxicity, oxygen radicals, transition metals and disease
34. A catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage
35. Lipoproteins in normal and atherosclerotic aorta
36. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque
37. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: Two procoagulant activities are produced by peripheral blood mononuclear cells
38. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro
39. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells
40. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein: Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface
41. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages: Relationship to tissue factor induction by cholesterol and oxidized LDL
42. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes
43. Tissue factor expression in human arterial smooth muscle cells: Tissue factor is present in three cellular pools after growth factor stimulation
44. Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway
45. Relations between factor Vlla binding and expression of factor Vlla/tissue factor catalytic activity on cell surfaces
46. Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation
47. Role of the membrane surface in the activation of human coagulation factor X
48. Mechanisms of cell injury by activated oxygen species
49. Copper-induced tissue factor expression in human monocytic THP-1 cells and its inhibition by antioxidants
50. Posttranscriptional regulation of macrophage tissue factor expression by antioxidants